{"id":"https://openalex.org/W2340993439","doi":null,"title":"Assessment of erlotinib in chemoresponse assay.","display_name":"Assessment of erlotinib in chemoresponse assay.","publication_year":2009,"publication_date":"2009-06-01","ids":{"openalex":"https://openalex.org/W2340993439","mag":"2340993439","pmid":"https://pubmed.ncbi.nlm.nih.gov/19528457"},"language":"en","primary_location":{"id":"pmid:19528457","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19528457","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090110104","display_name":"Shara D. Rice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098003","display_name":"Precision Therapeutics (United States)","ror":"https://ror.org/00shwmt46","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098003"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shara D Rice","raw_affiliation_strings":["Precision Therapeutics, Inc., Pittsburgh, PA 15203, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Therapeutics, Inc., Pittsburgh, PA 15203, U.S.A","institution_ids":["https://openalex.org/I4210098003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023450072","display_name":"Jason E. Bush","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason E Bush","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5041136752","display_name":"Stacey L. Brower","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stacey L Brower","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2553,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.63636364,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"29","issue":"6","first_page":"1993","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor-inhibition","display_name":"epidermal growth factor receptor inhibition","score":0.8920000195503235},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9869999885559082},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.6240000128746033},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7279999852180481},{"id":"https://openalex.org/keywords/cancer-cell-lines","display_name":"cancer cell lines","score":0.5389999747276306},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.9920839667320251},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6570243239402771},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6336889863014221},{"id":"https://openalex.org/C2909325608","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib Hydrochloride","level":5,"score":0.581156849861145},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5499030947685242},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5012953281402588},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4841897785663605},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4766969382762909},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43906399607658386},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4102935791015625},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34016382694244385},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.33946293592453003},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33239591121673584},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31043630838394165},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.05323958396911621},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:19528457","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19528457","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1915052583","https://openalex.org/W1967332050","https://openalex.org/W1970476748","https://openalex.org/W2005216767","https://openalex.org/W2037139573","https://openalex.org/W2049484790","https://openalex.org/W2096418206","https://openalex.org/W2098455835","https://openalex.org/W2110835998","https://openalex.org/W2111599976","https://openalex.org/W2127101185","https://openalex.org/W2131831783","https://openalex.org/W2134964659","https://openalex.org/W2135507887","https://openalex.org/W2138297714","https://openalex.org/W2139236349","https://openalex.org/W2142850084","https://openalex.org/W2145835533","https://openalex.org/W2145907510","https://openalex.org/W2152755651","https://openalex.org/W2153477391","https://openalex.org/W2157824687","https://openalex.org/W2161821474","https://openalex.org/W2162724777","https://openalex.org/W2163707745","https://openalex.org/W2225303308","https://openalex.org/W2297979315"],"related_works":["https://openalex.org/W2240633508","https://openalex.org/W2624873732","https://openalex.org/W2098073930","https://openalex.org/W1718904786","https://openalex.org/W2916385328","https://openalex.org/W2090154892","https://openalex.org/W2590039220","https://openalex.org/W2008005369","https://openalex.org/W2207571254","https://openalex.org/W2332747877"],"abstract_inverted_index":{"BACKGROUND:":[0],"There":[1],"is":[2],"a":[3],"need":[4],"to":[5,12,20,50,57,113,134,150],"identify":[6],"the":[7,73,80,105],"subset":[8],"of":[9,104],"patients":[10],"sensitive":[11],"epidermal":[13],"growth":[14,92],"factor":[15],"receptor":[16],"(EGFR)":[17],"inhibition":[18,93],"prior":[19],"using":[21],"such":[22],"treatments.":[23],"MATERIALS":[24],"AND":[25],"METHODS:":[26],"Three":[27],"non-small":[28],"cell":[29,33,61,101],"lung":[30,43,65],"cancer":[31],"(NSCLC)":[32],"lines":[34,62],"(H292,":[35],"H358,":[36],"and":[37,39,63,79,120,152],"Calu3)":[38],"34":[40,106],"primary":[41],"human":[42,64,138],"tumor":[44,66,91],"specimens":[45],"were":[46,71,76,83,87,111,117,123],"tested":[47],"for":[48,137],"chemoresponse":[49,129],"erlotinib.":[51],"RESULTS:":[52],"The":[53,68,126],"assay":[54,130],"distinguished":[55],"responsiveness":[56],"erlotinib":[58,95,151],"among":[59],"NSCLC":[60],"explants.":[67],"H292":[69],"cells":[70,75,82],"responsive,":[72],"Calu3":[74],"intermediate":[77,118],"responsive":[78,112,119],"H358":[81],"non-responsive.":[84,124],"These":[85],"results":[86],"consistent":[88],"with":[89],"published":[90],"by":[94],"in":[96,127,140],"xenografts":[97],"derived":[98],"from":[99],"these":[100],"lines.":[102],"Out":[103],"patient":[107,148],"specimens,":[108],"3":[109],"(8.8%)":[110],"erlotinib,":[114],"7":[115],"(20.6%)":[116],"24":[121],"(70.6%)":[122],"CONCLUSION:":[125],"vitro":[128],"profile":[131],"was":[132],"similar":[133],"that":[135],"noted":[136],"tumors":[139],"clinical":[141],"trials.":[142],"Chemoresponse":[143],"testing":[144],"may":[145],"help":[146],"predict":[147],"response":[149],"assist":[153],"chemotherapy":[154],"decision-making.":[155]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}